Compare Revenue Per Share Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Revenue Per Share Analysis
Compare Crinetics Pharmaceuticals, Enanta Pharmaceuticals, and Amicus Therapeutics Revenue Per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | 0.0424 | 0.0424 | 0.0424 | 0.0424 | 0.0424 | 0.0424 | 0.0424 | 0.1474 | 0.2 | 0.0493 | 0.0023 | 0.028 | 0.0911 | 0.0691 | 0.0866 |
| ENTA | 1.7859 | 36.0139 | 3.2747 | 2.601 | 8.6156 | 4.6631 | 5.3925 | 10.0061 | 10.4778 | 6.1421 | 4.8126 | 4.1819 | 3.7772 | 3.1968 | 3.04 |
| FOLD | 0.1348 | 0.62 | 0.4041 | 0.0071 | 0.0164 | 0.0369 | 0.0369 | 0.2408 | 0.4911 | 0.758 | 1.0078 | 1.1256 | 1.139 | 1.353 | 1.42 |
| CNTB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| LGND | 4.6231 | 1.5282 | 1.6433 | 2.411 | 3.1608 | 3.6339 | 5.2313 | 6.7089 | 10.4567 | 6.3323 | 11.518 | 16.6646 | 11.6342 | 7.5913 | 5.38 |
| PASG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ORIC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| LYEL | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0027 | 0.0315 | 0.0439 | 0.3427 | 5.0E-4 | 5.0E-4 |
| DSGN | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RVMD | 0.5529 | 0.5529 | 0.5529 | 0.5529 | 0.5529 | 0.5529 | 0.5529 | 0.5529 | 0.5529 | 0.8481 | 0.6454 | 0.4037 | 0.4388 | 0.1023 | 0.0972 |
Crinetics Pharmaceuticals, Enanta Pharmaceuticals, and Amicus Therapeutics Revenue Per Share description
The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.Generate Optimal Portfolios
The classical approach to portfolio optimization is known as Modern Portfolio Theory (MPT). It involves categorizing the investment universe based on risk (standard deviation) and return, and then choosing the mix of investments that achieves the desired risk-versus-return tradeoff. Portfolio optimization can also be thought of as a risk-management strategy as every type of equity has a distinct return and risk characteristics as well as different systemic risks, which describes how they respond to the market at large. Macroaxis enables investors to optimize portfolios that have a mix of equities (such as stocks, funds, or ETFs) and cryptocurrencies (such as Bitcoin, Ethereum or Monero)
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |